<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:31:51Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:2364106" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:2364106</identifier><datestamp>2009-09-10</datestamp><setSpec>brjcancer</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://dtd.nlm.nih.gov/ns/archiving/2.3/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://dtd.nlm.nih.gov/ns/archiving/2.3/ https://dtd.nlm.nih.gov/archiving/2.3/xsd/archivearticle.xsd" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Br J Cancer</journal-id>
      <journal-title>British Journal of Cancer</journal-title>
      <issn pub-type="ppub">0007-0920</issn>
      <issn pub-type="epub">1532-1827</issn>
      <publisher>
        <publisher-name>Nature Publishing Group</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC2364106</article-id>
      <article-id pub-id-type="pmcid">PMC2364106</article-id>
      <article-id pub-id-type="pmc-uid">2364106</article-id>
      <article-id pub-id-type="pmid">11506491</article-id>
      <article-id pub-id-type="pii">6691944</article-id>
      <article-id pub-id-type="doi">10.1054/bjoc.2001.1944</article-id>
      <article-id pub-id-type="pmid">11506491</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Regular Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A common founder for the V126D <italic>CDKN2A</italic> mutation in seven North American melanoma-prone families</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Goldstein</surname>
            <given-names>A M</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>L</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Shennan</surname>
            <given-names>M G</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hogg</surname>
            <given-names>D</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
          <xref ref-type="aff" rid="aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tucker</surname>
            <given-names>M A</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Struewing</surname>
            <given-names>J P</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, 20892, USA</aff>
      <aff id="aff2"><label>2</label>Department of Medicine, The University of Toronto, Toronto, Ontario, M5S 1A8, Canada</aff>
      <aff id="aff3"><label>3</label>Department of Division of Medical Oncology, Toronto-Sunnybrook Regional Cancer Centre, Toronto, Ontario, M4N 3M5, Canada</aff>
      <aff id="aff4"><label>4</label>Department of Medical Biophysics, Toronto-Sunnybrook Regional Cancer Centre, Toronto, Ontario, M4N 3M5, Canada</aff>
      <pub-date pub-type="ppub">
        <month>08</month>
        <year>2001</year>
      </pub-date>
      <volume>85</volume>
      <issue>4</issue>
      <fpage>527</fpage>
      <lpage>530</lpage>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>02</month>
          <year>2001</year>
        </date>
        <date date-type="rev-recd">
          <day>22</day>
          <month>05</month>
          <year>2001</year>
        </date>
        <date date-type="accepted">
          <day>30</day>
          <month>05</month>
          <year>2001</year>
        </date>
      </history>
      <copyright-statement>Copyright 2001, Cancer Research Campaign</copyright-statement>
      <copyright-year>2001</copyright-year>
      <permissions>
        <copyright-holder>Cancer Research Campaign</copyright-holder>
      </permissions>
      <abstract>
        <p>One of the most common melanoma-related <italic>CDKN2A</italic> mutations reported in North America is the V126D mutation. We examined nine markers surrounding <italic>CDKN2A</italic> in three American and four Canadian families carrying the V126D mutation. All seven families had a haplotype consistent with a common ancestor/founder for this mutation. In addition, the mutation appears to have originated 34â52 generations ago (1-LOD-unit support interval 13â98 generations). Â© 2001 Cancer Research Campaign <ext-link ext-link-type="uri" xlink:href="http:///www.bjcancer.com">http:///www.bjcancer.com</ext-link></p>
      </abstract>
      <kwd-group>
        <kwd>melanoma</kwd>
        <kwd>
          <italic>CDKN2A</italic>
        </kwd>
        <kwd>V126D</kwd>
        <kwd>founder</kwd>
      </kwd-group>
    </article-meta>
  </front>
</article>

</metadata></record></GetRecord></OAI-PMH>